Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
Tweet Send to a FriendGet Alerts ALXA Hot Sheet
Price: $4.59 +1.77%
EPS Growth %: -3,175.0%
Financial Fact:
Total operating expenses: 10.33M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: -3,175.0%
Financial Fact:
Total operating expenses: 10.33M
Today's EPS Names:
ANF, DXLG, FL, More
Trade ALXA Now!
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) reported Q4 GAAP EPS of $0.42, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $20.88 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
